PLANETS
4.2.2020 03:02:07 CET | Business Wire | Press release
teamLab Planets TOKYO is a museum in Toyosu, Tokyo where you walk through water and can immerse yourself in massive artworks barefoot. In the first year since teamLab Planets TOKYO opened in July of 2018, there have been more than 1.25 million visitors from 106 countries and regions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200203005275/en/
At teamLab Planets TOKYO, two artworks in the museum will be transformed by cherry blossoms for a limited time from March 1 to April 30, 2020.
Also, with the opening of the Toyosu Fish Market and Edomae Jokamachi nearby, you can enjoy food made using fresh ingredients, collect Japanese Culture souvenirs, and enjoy local shopping.
- Cherry Blossoms Transform Two Artworks
In the work Floating in the Falling Universe of Flowers , flowers bloom and change with every passing minute, creating a universe of life that spreads across the space. For a limited time only, cherry blossoms fall in the art space.
In another artwork, Drawing on the Water Surface Created by the Dance of Koi and People - Infinity , visitors walk barefoot through real water, as koi swim across the infinite water's surface. When the koi collide with people, they bloom into cherry blossoms. The flowers that bloom change in real time according to the seasonal changes of the year.
Check the teamLab Planets website for more details: https://planets.teamlab.art/
teamLab Planets highlight video: https://youtu.be/cqiv_FV8iT4
- Become Bodily Immersed in a Massive Art Space
teamLab Planets is a museum where you walk through water. It consists of 4 vast exhibition spaces with 7 distinct artworks. The artworks are based on art collective teamLab’s concept of “Body Immersive.”
By immersing the entire body with other people in these massive “Body Immersive” artworks, the boundary between the body and the artwork dissolves, the boundaries between the self, others, and the world become something continuous, and we explore a new relationship without boundaries between ourselves and the world.
Visitors enter the museum barefoot, and become completely immersed with other visitors in the vast artwork spaces.
- Artworks Transformed by Cherry Blossoms
Floating in the Falling Universe of Flowers
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/fitfuof/
Video: https://youtu.be/FzJ5svgIueQ
A seasonal year of flowers bloom and change with time, life spreads out into the universe.
Lie down or sit still in the space and eventually your body floats and you dissolve into the artwork world.
The artwork is rendered in real time by a computer. I is neither prerecorded nor on loop. Interaction between the viewer and the installation causes continuous change in the artwork.
Flowers grow, bud, bloom, and in time, the petals fall, and the flowers wither and die. The cycle of birth and death continues for perpetuity.
The universe at this moment in time can never be seen again.
Drawing on the Water Surface Created by the Dance of Koi and People - Infinity
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/koi_and_people/
Video: https://youtu.be/SsRNptTOniw
Koi swim on the surface of water that stretches out into infinity. People can walk into the water.
The movement of the koi is influenced by the presence of people in the water and also other koi. When the fish collide with people they turn into flowers and scatter. Throughout a year, the flowers that bloom will change along with the seasons.
The trajectory of the koi is determined by the presence of people and these trajectories trace lines on the surface of the water.
The work is rendered in real time by a computer program. It is neither prerecorded nor on loop. The interaction between the viewer and the installation causes continuous change in the artwork. Previous visual states can never be replicated, and will never reoccur.
- Museum overview
teamLab Planets TOKYO
Address: teamLab Planets TOKYO, Toyosu 6-1-16, Koto-ku, Tokyo
Hours: Monday - Thursday 10:00 - 19:00
Friday 10:00 - 21:00
Saturday and the day before holidays 9:00 - 21:00
Sunday and Holidays 9:00 - 19:00
* Last entry 30 minutes before closing.
* Special hours Friday, March 20 - Saturday, April 4: 9:00 - 21:00
* Special hours Sunday, April 5: 9:00 - 19:00
Closed:
Thursday, February 13, 2020
Thursday, March 12, 2020
Monday, April 6, 2020
Tuesday, April 14, 2020
Wednesday, April 15,2020
Admission:
Adults (18 years and older) JPY 3,200
University students / Specialized students JPY 2,500
Junior high school students / High school students JPY 2,000
Children (Ages 4-12) JPY 800
Seniors (65 years and older) JPY 2,400
Disability discount JPY 1,600
teamLab Planets website: https://planets.teamlab.art/
teamLab Planets TOKYO Ticket Store: https://teamlabplanets.dmm.com
* Prices and opening hours are subject to change. Please check the official website before visiting.
- Social Networking Sites:
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
#teamLabPlanets
- Jointly Managed Food Stand
Everything is in your hand
- Hours -
Monday - Thursday 10:00 - 18:00
Friday 10:00 - 20:00
Saturday and the day before holidays 10:00 - 20:00
Sunday and Holidays 10:00 - 18:00
- Closed -
Same as teamLab Planets
* Establishment may be closed in cases of extreme weather.
Check here for more information: https://planets.teamlab.art/tokyo/foodstand
PLANETS Co., Ltd.
The managing entity for facilities operations at teamLab Planets TOKYO and the associated restaurants.
Address: Tokyo Nihonbashi Tower 26F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
Representative: Takumi Nomoto
teamLab
teamLab (f. 2001) is an international art collective, an interdisciplinary group of various specialists such as artists, programmers, engineers, CG animators, mathematicians and architects whose collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world.
teamLab aims to explore the relationship between the self and the world and new perceptions through art. In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perception of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity of life.
teamLab has been the subject of numerous exhibitions at venues worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, Taipei, and Melbourne among others. The permanent museums teamLab Borderless opened in Odaiba, Tokyo in June 2018, and teamLab Borderless Shanghai in Huangpu District, Shanghai on November 5, 2019. The massive body immersive space teamLab Planets in Toyosu, Tokyo is on view until Fall 2020. The latest permanent museum teamLab SuperNature in Macao to launch in March, 2020.
teamLab’s works are in the permanent collection of the Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.
teamLab is represented by Pace Gallery .
teamLab: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
facebook: https://www.facebook.com/teamLab.inc
twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART
View source version on businesswire.com: https://www.businesswire.com/news/home/20200203005275/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom